Search Results - "Seher, Axel"
-
1
Fibroblast Growth Factor Inducible (Fn14)-specific Antibodies Concomitantly Display Signaling Pathway-specific Agonistic and Antagonistic Activity
Published in The Journal of biological chemistry (10-05-2013)“…The Fn14-specific monoclonal antibodies PDL192 and P4A8, which are under consideration in clinical trials, showed no agonistic activity with respect to IL8…”
Get full text
Journal Article -
2
Mass Spectrometric Metabolic Fingerprinting of 2-Deoxy-D-Glucose (2-DG)-Induced Inhibition of Glycolysis and Comparative Analysis of Methionine Restriction versus Glucose Restriction under Perfusion Culture in the Murine L929 Model System
Published in International journal of molecular sciences (16-08-2022)“…All forms of restriction, from caloric to amino acid to glucose restriction, have been established in recent years as therapeutic options for various diseases,…”
Get full text
Journal Article -
3
Receptor oligomerization and beyond: a case study in bone morphogenetic proteins
Published in BMC biology (07-09-2009)“…Transforming growth factor (TGF)beta superfamily members transduce signals by oligomerizing two classes of serine/threonine kinase receptors, termed type I and…”
Get full text
Journal Article -
4
The Influence of Met Receptor Level on HGF-Induced Glycolytic Reprogramming in Head and Neck Squamous Cell Carcinoma
Published in International journal of molecular sciences (11-01-2020)“…Head and neck squamous cell carcinoma (HNSCC) is known to overexpress a variety of receptor tyrosine kinases, such as the HGF receptor Met. Like other…”
Get full text
Journal Article -
5
HGF-Induced PD-L1 Expression in Head and Neck Cancer: Preclinical and Clinical Findings
Published in International journal of molecular sciences (20-11-2020)“…Head and neck squamous cell carcinoma (HNSCC) is a widespread disease with a low survival rate and a high risk of recurrence. Nowadays, immune checkpoint…”
Get full text
Journal Article -
6
Cysteine Restriction in Murine L929 Fibroblasts as an Alternative Strategy to Methionine Restriction in Cancer Therapy
Published in International journal of molecular sciences (27-10-2021)“…Methionine restriction (MetR) is an efficient method of amino acid restriction (AR) in cells and organisms that induces low energy metabolism (LEM) similar to…”
Get full text
Journal Article -
7
Metabolic Silencing via Methionine-Based Amino Acid Restriction in Head and Neck Cancer
Published in Current issues in molecular biology (24-05-2023)“…In recent years, various forms of caloric restriction (CR) and amino acid or protein restriction (AAR or PR) have shown not only success in preventing…”
Get full text
Journal Article -
8
The Selection of NFκB Inhibitors to Block Inflammation and Induce Sensitisation to FasL-Induced Apoptosis in HNSCC Cell Lines Is Critical for Their Use as a Prospective Cancer Therapy
Published in International journal of molecular sciences (15-03-2019)“…Inflammation is a central aspect of tumour biology and can contribute significantly to both the origination and progression of tumours. The NFκB pathway is one…”
Get full text
Journal Article -
9
Metabolic Fingerprinting of Murine L929 Fibroblasts as a Cell-Based Tumour Suppressor Model System for Methionine Restriction
Published in International journal of molecular sciences (16-03-2021)“…Since Otto Warburg reported in 1924 that cancer cells address their increased energy requirement through a massive intake of glucose, the cellular energy level…”
Get full text
Journal Article -
10
Crystal structure analysis reveals a spring-loaded latch as molecular mechanism for GDF-5-type I receptor specificity
Published in The EMBO journal (08-04-2009)“…Dysregulation of growth and differentiation factor 5 (GDF‐5) signalling, a member of the TGF‐β superfamily, is strongly linked to skeletal malformation…”
Get full text
Journal Article -
11
The anti-myeloma activity of bone morphogenetic protein 2 predominantly relies on the induction of growth arrest and is apoptosis-independent
Published in PloS one (13-10-2017)“…Multiple myeloma (MM), a malignancy of the bone marrow, is characterized by a pathological increase in antibody-producing plasma cells and an increase in…”
Get full text
Journal Article -
12
Utilizing BMP-2 muteins for treatment of multiple myeloma
Published in PloS one (10-05-2017)“…Multiple myeloma (MM) represents a haematological cancer characterized by the pathological hyper proliferation of antibody-producing B-lymphocytes. Patients…”
Get full text
Journal Article -
13
Type I receptor binding of bone morphogenetic protein 6 is dependent on N-glycosylation of the ligand
Published in The FEBS journal (01-01-2008)“…Bone morphogenetic proteins (BMPs), together with transforming growth factor (TGF)-β and activins/inhibins, constitute the TGF-β superfamily of ligands. This…”
Get full text
Journal Article -
14
Low Energy Status under Methionine Restriction Is Essentially Independent of Proliferation or Cell Contact Inhibition
Published in Cells (Basel, Switzerland) (04-02-2022)“…Nonlimited proliferation is one of the most striking features of neoplastic cells. The basis of cell division is the sufficient presence of mass (amino acids)…”
Get full text
Journal Article -
15
Structure Analysis of Bone Morphogenetic Protein-2 Type I Receptor Complexes Reveals a Mechanism of Receptor Inactivation in Juvenile Polyposis Syndrome
Published in The Journal of biological chemistry (29-02-2008)“…Bone morphogenetic proteins regulate many developmental processes during embryogenesis as well as tissue homeostasis in the adult. Signaling of bone…”
Get full text
Journal Article -
16
Exogenous TNFR2 activation protects from acute GvHD via host T reg cell expansion
Published in The Journal of experimental medicine (22-08-2016)“…Donor CD4(+)Foxp3(+) regulatory T cells (T reg cells) suppress graft-versus-host disease (GvHD) after allogeneic hematopoietic stem cell transplantation (HCT…”
Get full text
Journal Article -
17
Studies of Binding of Tumor Necrosis Factor (TNF)-like Weak Inducer of Apoptosis (TWEAK) to Fibroblast Growth Factor Inducible 14 (Fn14)
Published in The Journal of biological chemistry (02-01-2012)“…To perform highly sensitive cellular binding studies with TNF-like weak inducer of apoptosis (TWEAK), we developed a bioluminescent variant of soluble TWEAK…”
Get full text
Journal Article -
18
MLN4924 sensitizes monocytes and maturing dendritic cells for TNF‐dependent and ‐independent necroptosis
Published in British journal of pharmacology (01-03-2015)“…Background and Purpose MLN4924 prevents the formation of active cullin‐RING ubiquitin ligase complexes and thus inhibits NF‐κB signalling. Here, we evaluated…”
Get full text
Journal Article -
19
Repurposing of quinoline alkaloids identifies their ability to enhance doxorubicin‐induced sub‐G0/G1 phase cell cycle arrest and apoptosis in cervical and hepatocellular carcinoma cells
Published in Biotechnology and applied biochemistry (01-08-2021)“…The ability of quinoline alkaloids (cinchonine, cinchonidine, quinine, and quinidine) to sensitize different human cancer cell lines to doxorubicin…”
Get full text
Journal Article -
20
Soluble and transmembrane TNF-like weak inducer of apoptosis differentially activate the classical and noncanonical NF-kappa B pathway
Published in The Journal of immunology (1950) (01-08-2010)“…TNF-like weak inducer of apoptosis, TWEAK, is a typical member of the TNF ligand family. Thus, it is initially expressed as a type II transmembrane protein…”
Get full text
Journal Article